Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2001
09/05/2001CN1311309A New polypeptide-human signal conductive protein kinase 17 and polynucleotide for coding such polypeptide
09/05/2001CN1311307A New polypeptide-HNK-1 sulfotransferase 48 and polynucleotide for coding such polypeptide
09/05/2001CN1311306A New polypeptide-estrin sulfotransferase 36 and polynucleotide for coding such polypeptide
09/05/2001CN1311305A New polypeptide-heparan sulfate 3-0-sulfotransferase 19 and polynucleotide for coding such polypeptide
09/05/2001CN1311304A New polypeptide-peroxide enzyme 8 and polynucleotide for coding such polypeptide
09/05/2001CN1311302A New polypeptide-human glucoprotein glucosyl transport enzyme 17 and polynucleotide coding such polypeptide
09/05/2001CN1311300A New polypeptide-human threonine-tRNA synthetase 14 and polynucleotide for coding such polypeptide
09/05/2001CN1311254A New polypeptide-human TNFR/NGER protein 13 containing cytochrome C structure region and polynucleotide for coding such polypeptide
09/05/2001CN1311253A New polypeptide-human excitable amino acid transport protein 9 and polynucleotide for coding such polypeptide
09/05/2001CN1311252A New polypeptide-human reverse transcript relative protein 9 and polynucleotide for coding such polypeptide
09/05/2001CN1311246A New polypeptide-human FD17 and polynucleotide for coding such polypeptide
09/05/2001CN1311241A New polypeptide-human beta preprotachykinin 12 and polynucleotide for coding such polypeptide
09/05/2001CN1311239A New polypeptide-human reverse transcript relative factor 33 and polynucleotide for coding said polypeptide
09/05/2001CN1311237A New polypeptide-human cell factor receptor 12 and polynucleotide for codign said polypeptide
09/05/2001CN1311236A New polypeptide-human molecular partner cpn60 protein 26 and polynucleotide for coding said polypeptide
09/05/2001CN1311235A New polypeptide-human reverse trancript relative factor 15 and polynucleotide for coding said polypeptide
09/05/2001CN1311233A New polypeptide-human nuclear fabric layer protein 14 and polynucleotide for coding said polypeptide
09/05/2001CN1311232A New polypeptide-human retina tumor protein 22 and polynucleotide for coding said polypeptide
09/05/2001CN1311228A New polypeptide-human sperm specific protein EM1, EM6-48 and polynucleotide for coding said polypeptide
09/05/2001CN1311226A New polypeptide-human plasminogen activator inhibitor 2-9 and polynucleotide for coding said polypeptide
09/05/2001CN1311223A New polypeptide-human ribosome S5-17 and polynucleotide for coding said polypeptide
09/05/2001CN1311220A New polypeptide-human cell programe death negative regulating factor 21 and polynucleotide for coding said polypeptide
09/05/2001CN1311218A New polypeptide-human nucleotransfer protein 12 containing ATP/GTP combination structure zone and polynucleotide coding for said polypeptide
09/05/2001CN1311217A New polypeptide-human fibroblastic growth factor autofactor 1-25 and polynucleotide for coding said polypeptide
09/05/2001CN1311216A New polypeptide-human microtubulin 11 and polynucleotide for coding said polypeptide
09/05/2001CN1311208A New polypeptide-human beta-pre-protachy kinin 9 and polynucleotide for coding said polypeptide
09/05/2001CN1311204A New polypeptide-human adenosine triphosphate 30 and polynucleotide for coding said polypeptide
09/05/2001CN1311202A New polypeptide-human reverse transcription relative factor 22 and polynucleotide for coding said polypeptide
09/05/2001CN1311198A New polypeptide-clathrin light chain 38 and polynucleotide for coding said polypeptide
09/05/2001CN1311195A New polypeptide-clathrin ligh chain 21 and polynucleotide for coding said polypeptide
09/05/2001CN1311194A New polypeptide-ribosome s19e protein 11 and polynucleotide for coding said polypeptide
09/05/2001CN1311035A Recombination high efficiency composite interferon used as hepatitis B surface antigen and e antigen inhibitor
09/05/2001CN1311034A Use of LT limulus peptide in preparing anti-cancer medicine
09/05/2001CN1070500C Analogs of paratyroid hormone and parathyroid hormone related peptide; synthesis and use for treating osteoporosis
09/05/2001CN1070380C Method for prodn. of HDL
09/05/2001CN1070371C Medicine for treating HIV-seropositive individuals medicine
09/04/2001US6284881 A nucleic acid molecule; diagnosis and therpy for allergies, parasitic infections, b cell neoplasia and atopic diseases
09/04/2001US6284879 A nucleic acid encoding a transporter protein; treatment of autoimmune disorders and improving immune responses
09/04/2001US6284878 def1
09/04/2001US6284872 Tendon-inducing compositions
09/04/2001US6284871 A peptide of 8-20 amino acids involved in binding to activated factor ix; drug therpy for thrombotic disorders
09/04/2001US6284870 Gamma retinoic acid receptor
09/04/2001US6284862 Monomers derived from hydroxy acids and polymers prepared therefrom
09/04/2001US6284802 Methods for regulating the condition of mammalian keratinous tissue
09/04/2001US6284790 Methods of potentiating organic nitrates having vasodilating activity and formulations for the same
09/04/2001US6284787 Use of R-(+)-α-lipoic acid, R-(−)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae
09/04/2001US6284778 Neurotrophic agent
09/04/2001US6284777 Carbohydrazide protease inhibitors
09/04/2001US6284767 Retroviral protease inhibiting compounds
09/04/2001US6284743 Method for modulating smooth muscle cell proliferation
09/04/2001US6284741 Genetic engineered nucleic acid
09/04/2001US6284740 Osteoprotegerin
09/04/2001US6284734 Nonapeptide
09/04/2001US6284732 Polypeptides
09/04/2001US6284731 Polypeptides
09/04/2001US6284730 Administering parathyroid hormone
09/04/2001US6284728 Osteoprotegerin
09/04/2001US6284727 Polypeptide on a polymer carrier; antidiabetic agent
09/04/2001US6284726 Administering polypeptide
09/04/2001US6284725 Administering binding compound for glucagon receptor such asglucagon-like peptide
09/04/2001US6284540 Neuronal trophic support and cell differentiation by introducing nucleotide sequence
09/04/2001US6284538 Oligonucleotide used for diabetes and cancer treatment
09/04/2001US6284536 Modified immunoglobin molecules and methods for use thereof
09/04/2001US6284535 Splice variants of the heregulin gene, nARIA and uses thereof
09/04/2001US6284515 Signal recognition particle polypeptides and polynucleotides
09/04/2001US6284513 Culturing escherichia coli host cell transformed with a dna sequence encoding catalytic domain of stromelysin protein; lack of c-terminal and propeptide fragments eliminates autolysis and need for proteolytic activation
09/04/2001US6284509 Enzyme with β-1,3-glucanase activity
09/04/2001US6284508 Glucuronoxylomannan (GXM)-O-acetylhydrolase of Cryptococcus neoformans and uses thereof
09/04/2001US6284505 Excitatory amino acid transporter (EAAT) 5 protein from homo sapiens
09/04/2001US6284491 Biologically active synthetic thyrotropin and cloned gene for producing same
09/04/2001US6284489 Enzymatic polypeptide for use in screening bactericides; wound healing agents; for prevention of bacterial infections
09/04/2001US6284486 Human oncogene induced secreted protein I
09/04/2001US6284485 Nucleic acids encoding osteoprotegerin
09/04/2001US6284476 Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals
09/04/2001US6284471 Chimeric immunoglobulin; for the diagnosis and treatment of bacterial infection, cancer and septic shock
09/04/2001US6284464 Inhibition of binding of Hox and homeodomain-containing proteins and uses thereof
09/04/2001US6284456 Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor
09/04/2001US6284454 Variant of LAV viruses
09/04/2001US6284452 Administering aqueous solution containing potassium, magnesium, sodium, calcium, chloride, oncotic agent, carboxylic acid or salt, sugar and clotting factor
09/04/2001US6284290 For improving bowel movement of patients who have undergone intestinal ablation or patients with an artificial anus
09/04/2001US6284287 For administering drugs by breathing
09/04/2001US6284283 Method of producing sub-micron particles of biologically active agents and uses thereof
09/04/2001US6284282 Method of spray freeze drying proteins for pharmaceutical administration
09/04/2001US6284268 Cyclosporin, synergistic
09/04/2001US6284260 Treatment with erythropoietin of bleeding from benign and malignant lesions with normal and abnormal coagulation parameters
09/04/2001US6284255 Compounds and methods for treatment and diagnosis of mycobacterial infections
09/04/2001US6284252 Transdominant TAT variants of the human immunodeficiency virus
09/04/2001US6284249 Fusion polypeptide having the C protein and E1 protein of hepatitis C virus
09/04/2001US6284248 Immunogenic compositions comprising soluble, non-cleavable, chimeric HIV-1 gp160-variants
09/04/2001US6284247 Human tissue plasminogen activators
09/04/2001US6284245 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders
09/04/2001US6284244 Mediating the effects of alcohol consumption by orally administering active dry yeast
09/04/2001US6284241 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
09/04/2001US6284240 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
09/04/2001US6284237 Methods of treatment using IL-6
09/04/2001US6282837 Methods of controlling the growth of undesired vegetation with herbicide tolerant plants or plant seeds having altered protoporphyrinogen oxidase activity
09/04/2001CA2205430C Method for making a medicament for treating secondary immunodeficiency
09/04/2001CA2167281C Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
09/04/2001CA2039491C Stable compositions for parenteral administration and method of making same
08/2001
08/30/2001WO2001063295A2 Dpi-6, a therapeutic biomarker in neurological disorders